Calcification inhibitors in vascular calciphylaxis associated with normal renal function

Thrombosis and Haemostasis

Volumn 108, Issue 6, 2012, Pages 1241-1243

  Brandenburg, Vincent ^a   Al Fakhri, Nadia ^b   Nemeth, Katharina ^b   Goettsch, Claudia ^c   Schurgers, Leon J ^d   Vermeer, Cees ^d   Hofbauer, Lorenz C ^c   Schoppet, Michael ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; COLECALCIFEROL; FETUIN A; HEPARIN; OPIATE; OSTEOCALCIN; OSTEOPROTEGERIN; PHENPROCOUMON; SEVELAMER; SODIUM THIOSULFATE; VITAMIN K GROUP;

ADULT; ARTICLE; BLOOD VESSEL CALCIFICATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROTHROMBUS; PRIORITY JOURNAL; SEPTICEMIA; SKIN BIOPSY; SKIN DEFECT; SKIN NECROSIS; SKIN PAIN; SOFT TISSUE DISEASE; SUBCUTANEOUS NODULE; ULCER;

ALPHA-2-HS-GLYCOPROTEIN; CALCINOSIS; CALCIPHYLAXIS; CALCIUM-BINDING PROTEINS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; KIDNEY FUNCTION TESTS; MALE; OSTEOPROTEGERIN; VASCULAR DISEASES; YOUNG ADULT;

EID: 84871423831     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-07-0484     Document Type: Article

References (10)

1. Brandenburg VM, Cozzolino M, Ketteler M. Calciphylaxis: a still unmet challenge. J Nephrol 2011; 24: 142-148.
2. Shanahan CM, Crouthamel MH, Kapustin A, et al. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 2011; 109: 697-711.
3. Nigwekar SU, Wolf M, Sterns RH, et al. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol 2008; 3: 1139-1143.
4. Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003; 361: 827-833.
5. Cranenburg EC, Koos R, Schurgers LJ, et al. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost 2010; 104: 811-822.
6. Cranenburg EC, Vermeer C, Koos R, et al. The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res 2008; 45: 427-436.
7. Arenas MD, Gil MT, Gutiérrez MD, et al. Management of calcific uremic arteriolopathy (calciphylaxis) with a combination of treatments, including hyperbaric oxygen therapy. Clin Nephrol 2008; 70: 261-264.
8. Hristova M, van Beek C, Schurgers LJ, et al. Rapidly progressive severe vascular calcification sparing the kidney allograft following warfarin initiation. Am J Kidney Dis 2010; 56: 1158-1162.
9. Price PA, Faus SA, Williamson MK. Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol 2000; 20: 317-327.
10. Baldwin C, Farah M, Leung M, et al. Multi-intervention management of calciphylaxis: a report of 7 cases. Am J Kidney Dis 2011; 58: 988-991.